Management of obese Type1 Diabetes Mellitus (Double Diabetes | 96282

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Management of obese Type1 Diabetes Mellitus (Double Diabetes) through Telemedicine during COVID 19 pandemic lockdown

Author(s): Swar Sunil Gupta*, Sangeeta Totade, Kavita Gupta, Parvinder Bamrah, Shlok Gupta, Sunil Gupta


Introduction: Prevalence of obesity in type 1DM (T1DM), with features of type 2DM (double diabetes) is increasing, which is an independent risk factor for vasculopathy. Achieving glycaemic control, avoiding insulin-related weight gain and preventing hypoglycemia is challenging in such cases during pandemic. Telemedicine may be effectively used for therapeutic diabetes education. Aim: To manage a case of morbidly obese uncontrolled T1DM, through intensive online lifestyle modification (LSM), during COVID19 lockdown. Case Details: A 33year old morbidly obese female (BMI: 30.1Kg/m2) with T1DM of 24 years duration, having sedentary lifestyle, presented with uncontrolled diabetes (HbA1c-8.7%), despite high total daily dose (TDD) of insulin (140U/Day), limitation of movements, easy fatigue and emotional instability. She had polycystic ovarian syndrome with hypertension and was on metformin, voglibose & telmisartan. First teleconsultation was done in September 2020. Methodology: Teleconsultation for medical nutrition therapy (MNT), exercise, insulin dose adjustments through self-monitoring of blood glucose was done by nutritionist, diabetes educator (DE) and clinician. Modification in total calories intake (reduced by 500-600Kcals/day), food frequency and macronutrient content were done. Regular brisk walk/jogging (45-50mins/day) was advised. Depression was assessed by using PHQ9 questionnaire. Compliance was assessed weekly by DE. Results: At 16 weeks post-intervention, she lost 11.5% of weight. HbA1c reduced by 1% from baseline and TDD of insulin reduced by 57.14%, with no episode of hypoglycemia or ketosis. PHQ9 questionnaire score reduced from 6 to 2. Conclusion: Implementing diabetes education through telemedicine can help to reduce obesity, glycosylated HbA1c, insulin doses and risk of depression in a person with double diabetes.

Share this article